Yanfei Guo

3.4k total citations
22 papers, 257 citations indexed

About

Yanfei Guo is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Yanfei Guo has authored 22 papers receiving a total of 257 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 8 papers in Physiology and 4 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Yanfei Guo's work include Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers), Asthma and respiratory diseases (7 papers) and Respiratory Support and Mechanisms (7 papers). Yanfei Guo is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (14 papers), Asthma and respiratory diseases (7 papers) and Respiratory Support and Mechanisms (7 papers). Yanfei Guo collaborates with scholars based in China, Taiwan and Australia. Yanfei Guo's co-authors include Jean-Paul Janssens, Tieying Sun, Chen Wang, Yilin Huang, Hongsheng Zhang, Mingming Pan, Yuxia Wang, Weiming Liu, Ping Zeng and Hongxuan Xu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Functional Materials and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Yanfei Guo

19 papers receiving 254 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanfei Guo China 10 138 64 64 26 21 22 257
Avantika R. Diwadkar United States 5 69 0.5× 44 0.7× 44 0.7× 16 0.6× 17 0.8× 13 193
Jocelyn Biagini Myers United States 4 62 0.4× 95 1.5× 171 2.7× 23 0.9× 25 1.2× 10 333
Yanming Lu China 11 60 0.4× 112 1.8× 97 1.5× 15 0.6× 16 0.8× 36 312
Whitney D. Arroyave United States 13 39 0.3× 97 1.5× 107 1.7× 10 0.4× 22 1.0× 18 441
Karen Z. Voter United States 11 181 1.3× 132 2.1× 81 1.3× 68 2.6× 41 2.0× 20 400
Katherine Mills United States 8 82 0.6× 42 0.7× 120 1.9× 14 0.5× 30 1.4× 16 244
Sindaghatta Krishnarao Chaya India 11 168 1.2× 67 1.0× 75 1.2× 41 1.6× 29 1.4× 34 310
Nour Assad United States 9 175 1.3× 132 2.1× 116 1.8× 74 2.8× 26 1.2× 21 423
Toshiyuki Nishimuta Japan 11 160 1.2× 93 1.5× 209 3.3× 49 1.9× 23 1.1× 30 410
Olga Gorlanova Switzerland 11 104 0.8× 100 1.6× 67 1.0× 31 1.2× 30 1.4× 28 259

Countries citing papers authored by Yanfei Guo

Since Specialization
Citations

This map shows the geographic impact of Yanfei Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanfei Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanfei Guo more than expected).

Fields of papers citing papers by Yanfei Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanfei Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanfei Guo. The network helps show where Yanfei Guo may publish in the future.

Co-authorship network of co-authors of Yanfei Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Yanfei Guo. A scholar is included among the top collaborators of Yanfei Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanfei Guo. Yanfei Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guo, Yanfei, Siqi Li, Zhaoyue Lv, et al.. (2025). Programmable DNA‐Based Synthetic Organelles as Telomerase Traps for Cell Cycle Regulation in Cancer Cells. Advanced Functional Materials. 36(14).
2.
Huang, Ke, Xueyan Han, Jianping Zhao, et al.. (2024). Impact of Using Pre- and Postbronchodilator Spirometry Reference Values in a Chinese Population. American Journal of Respiratory and Critical Care Medicine. 210(7). 881–889. 1 indexed citations
3.
Cao, Yang, et al.. (2024). Predictive score for in-hospital mortality in patients with severe acute exacerbations of COPD. Archives of Medical Science. 21(2). 442–450.
4.
Guo, Yanfei, et al.. (2023). Construction of DNA aggregates in cell milieu for bio‐interference. SHILAP Revista de lepidopterología. 4(6). 6 indexed citations
5.
Yang, Ting, Xia Meng, Renjie Chen, et al.. (2023). Ambient particulate matter associates with asthma in high altitude region: A population-based study. World Allergy Organization Journal. 16(5). 100774–100774. 10 indexed citations
7.
Yang, Ting, Su Shi, Xia Meng, et al.. (2023). Combined effect of ozone and household air pollution on COPD in people aged less than 50 years old. Thorax. 79(1). 35–42. 15 indexed citations
8.
Guo, Yanfei, et al.. (2022). Prognostic value of lymphocyte count for in-hospital mortality in patients with severe AECOPD. BMC Pulmonary Medicine. 22(1). 376–376. 11 indexed citations
9.
Sun, Tieying, Jean-Paul Janssens, Weiming Liu, et al.. (2022). Airflow obstruction and small airway dysfunction following pulmonary tuberculosis: a cross-sectional survey. Thorax. 78(3). 274–280. 32 indexed citations
10.
Guo, Yanfei, Jie Liu, Xiuqing Huang, et al.. (2021). Association between IL-1B (-511)/IL-1RN (VNTR) polymorphisms and type 2 diabetes: a systematic review and meta-analysis. PeerJ. 9. e12384–e12384. 7 indexed citations
11.
Wang, Yuxia, et al.. (2021). Solid Fuel Exposure and Chronic Obstructive Pulmonary Disease in Never-Smokers. Frontiers in Medicine. 8. 757333–757333. 6 indexed citations
12.
Huang, Yilin, et al.. (2021). Predictors of mortality in COPD exacerbation cases presenting to the respiratory intensive care unit. Respiratory Research. 22(1). 77–77. 26 indexed citations
14.
Guo, Yanfei, Guangliang Shan, Jean-Paul Janssens, et al.. (2020). Prevalence and Risk Factors for COPD at High Altitude: A Large Cross-Sectional Survey of Subjects Living Between 2,100–4,700 m Above Sea Level. Frontiers in Medicine. 7. 581763–581763. 26 indexed citations
15.
Ruan, Zengliang, Zhengmin Qian, Yanfei Guo, et al.. (2019). Ambient fine particulate matter and ozone higher than certain thresholds associated with myopia in the elderly aged 50 years and above. Environmental Research. 177. 108581–108581. 42 indexed citations
16.
Huang, Kewu, Yanfei Guo, Jian Kang, et al.. (2019). The efficacy of adding budesonide/formoterol to ipratropium plus theophylline in managing severe chronic obstructive pulmonary disease: an open-label, randomized study in China. Therapeutic Advances in Respiratory Disease. 13. 3271588540–3271588540. 9 indexed citations
17.
Fingleton, James, Kewu Huang, Mark Weatherall, et al.. (2017). Phenotypes of symptomatic airways disease in China and New Zealand. European Respiratory Journal. 50(6). 1700957–1700957. 7 indexed citations
18.
Wang, Xiaohong, Baiqiang Cai, Kewu Huang, et al.. (2017). Perception of circadian variation of symptoms in Chinese patients with chronic obstructive pulmonary disease. Journal of Thoracic Disease. 9(10). 3888–3895. 5 indexed citations
19.
Wei, Yuan, et al.. (2015). Association of the IGF-1 rs35767 and rs972936 polymorphisms with the risk of osteoporosis in a Chinese postmenopausal female population. Genetics and Molecular Research. 14(4). 14325–14330. 7 indexed citations
20.
Guo, Yanfei, Tieying Sun, François R. Herrmann, & Jean-Paul Janssens. (2005). Comparison of airway resistance measurements by the forced oscillation technique and the interrupter technique for detecting chronic obstructive pulmonary disease in elderly patients.. PubMed. 118(22). 1921–4. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026